Ablative Fractional Laser Improves Treatment of Actinic Keratoses With Ingenol Mebutate

European Journal of Inflammation - United States
doi 10.1177/1721727x16674219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses

Dermatology and Therapy
Dermatology
2012English

Ingenol Mebutate: An Emerging Therapy in the Treatment of Actinic Keratoses

Current Dermatology Reports
Dermatology
2013English

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate

PLoS ONE
Multidisciplinary
2016English

Ingenol Mebutate Treatment in Actinic Keratosis – Clinical Effectiveness and Potential Side Effects

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Disruption of Latent HIV in Vivo During the Clearance of Actinic Keratosis by Ingenol Mebutate

JCI insight
Medicine
2019English

Recurrent in Situ Melanoma Successfully Treated With Ingenol Mebutate

Dermatology and Therapy
Dermatology
2014English

Field Cancerization Therapy With Ingenol Mebutate Contributes to Restoring Skin-Metabolism to Normal-State in Patients With Actinic Keratosis: A Metabolomic Analysis

Scientific Reports
Multidisciplinary
2019English

A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Successful Treatment of Relapsing Bowen's Disease With Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response

Dermatology
Dermatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy